Skip to main content
John Miles, MD, Endocrinology, Kansas City, KS, The University of Kansas Hospital

JohnMMilesMD

Endocrinology Kansas City, KS

Diabetes, Lipid Metabolism, Obesity

Professor, Internal Medicine, Mayo Medical School

Dr. Miles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Miles' full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1977 - 1981
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1975 - 1975
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1974 - 1974
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 1974
  • Southern Methodist University
    Southern Methodist UniversityB.A., 1969

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 1998 - 2024
  • MN State Medical License
    MN State Medical License 2002 - 2015
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1992
  • Stanley Dudrick Research Scholar Award 1985

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Report of the 9th SIG Tracer Methodology Meeting in Florence, 2008  
    Rooyackers O, Mori M, Miles J, e-SPEN, 1/1/2009
  • For Debate: No, the Glycaemic Target in the Critically Ill Should Not Be < or = 61 mmol/1  
    Miles JM, McMahon MM, Isley WL, Diabetologia, 1/1/2008
  • Combined Therapy with N-3 Fatty Acids and Niacin in Atherogenic Dyslipidemia  
    Isley WL, Miles JM, Harris WS, J Clin Lipidol, 1/1/2007
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Differential Patterns of Abdominal Adipose Tissue Loss in Pancreatic Cancer Vs Post Gastric Bypass Surgery
    Nagpal SJ, Sah RP, Takahashi N, Miles JM, Petersen GM, Mukhopadhyay D, Chari ST, Pancreas, 11/1/2013
  • The Relationship of Muscle Sympathetic Nerve Activity to the Sympathetically-mediated Thermic Effect of Food in Young Healthy Subjects
    Matzek LJ, Miles J, Jensen M, Levine J, Joyner M, Curry TB, FASEB J, 4/1/2013
  • Variability in Body Fat Depots among People with Type 2 Diabetes: Effect of Weight Loss
    Almandoz JP, Nelson RH, Miles JM, J Investig Med, 1/1/2013
  • Join now to see all

Lectures

  • Trafficking of Dietary and Endogenous Lipid Fuels: A New (Old) Role for Lipoprotein Lipase? 
    Vanderbilt University, Nashville, Tennessee - 4/1/2011
  • Tracer Methods for the Study of Precursor-Product Relationships in Lipid Metabolism 
    Florence, Italy - 9/1/2008
  • Control of Hyperglycemia in Hospitalized Patients 
    Alexandria, Egypt - 4/1/2008
  • Join now to see all

Grant Support

  • FFA Production From Triglyceride-Rich LipoproteinsNational Heart, Lung, And Blood Institute2004–2012
  • The Role Of Plasma Triglycerides In Myocardial Fuel MetabolismNational Center For Research Resources2005
  • Release Of Fatty Acids From Chylomicrons In Forearm And Adipose TissueNational Center For Research Resources2005
  • Effect Of Insulin Sensitizers On Lipid Metabolism In Obese, Dyslipidemic SubjectNational Center For Research Resources2005
  • Single IV Dose Of Etc-642 In Stable AtherosclerosisNational Center For Research Resources2004
  • FFA Production From Triglyceride-Rich LipoproteinsNational Heart, Lung, And Blood Institute2003
  • Regulation Of FFA Metabolism In Normal &Diabetic HumansNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1996
  • In Vivo Regulation Of Regional Lipolysis By The Sympathetic Nervous SystemNational Center For Research Resources1994
  • Effect Of Pulsatile Growth Hormone And Lipolysis In Normal HumansNational Center For Research Resources1994
  • Treatment Of Abnormal Insulin Kinetics And Insulin ResistanceNational Center For Research Resources1993–1994
  • Regulation Of FFA Metabolism In Normal &Diabetic HumansNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
  • Regional And Systemic Lipoprotein Kinetics In Post-AbsorptionNational Center For Research Resources1993
  • Substrate Regulation Of Free Fatty Acid, Leucine And Glucose MetabolismNational Center For Research Resources1991–1992
  • Regulation Of FFA Metabolism In Normal And Diabetic ManNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1991
  • Regulation Of Free Fatty Acid Metabolism In Normal And Diabetic ManNational Center For Research Resources1988
  • Effect Of Tolbutamide Dosage On Glycemic Control And Insulin Receptor In NIDDNational Center For Research Resources1985–1986
  • Effect Of Free Fatty Acids On Amino Acid And Glucose MetabolismNational Center For Research Resources1985–1986
  • BAY M 1099 And Glucose ToleranceNational Center For Research Resources1985–1986
  • Substrate And Hormonal Regulation Of Ketogenesis In VivoNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Professional Memberships

Hospital Affiliations